Predicting appropriate shocks in patients with heart failure: Patient levelmeta-analysis from SCD-HeFT and MADIT II

被引:22
作者
Zeitler, Emily P. [1 ]
Al-Khatib, Sana M. [1 ,2 ]
Friedman, Daniel J. [1 ,2 ]
Han, Joo Yoon [3 ]
Poole, Jeanne E. [3 ]
Bardy, Gust H. [3 ]
Bigger, J. Thomas [4 ]
Buxton, Alfred E. [6 ]
Moss, Arthur J. [5 ]
Lee, Kerry L. [2 ]
Dorian, Paul [7 ]
Cappato, Riccardo [8 ,9 ]
Kadish, Alan H. [10 ]
Kudenchuk, Peter J. [3 ]
Mark, Daniel B. [1 ,2 ]
Inoue, Lurdes Y. T. [3 ]
Sanders, Gillian D. [2 ]
机构
[1] Duke Univ Hosp, Durham, NC USA
[2] Duke Clin Res Inst, Duke Box 3485,7020 North Pavil Bldg, Durham, NC 27710 USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Columbia Univ, New York, NY USA
[5] Univ Rochester, Rochester, NY USA
[6] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[7] Univ Toronto, Toronto, ON, Canada
[8] Humanitas Univ, Milan, Italy
[9] Humanitas Clin Res Inst, Milan, Italy
[10] Northwestern Mem Hosp, Feinberg Sch Med, Chicago, IL 60611 USA
基金
美国国家卫生研究院; 美国医疗保健研究与质量局;
关键词
implantable cardioverter defibrillator; meta-analysis; primary prevention; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; CARDIAC-RESYNCHRONIZATION THERAPY; VENTRICULAR-ARRHYTHMIAS TOVA; CORONARY-ARTERY-DISEASE; NONISCHEMIC CARDIOMYOPATHY; PRIMARY PREVENTION; ISCHEMIC CARDIOMYOPATHY; FOLLOW-UP; DILATED CARDIOMYOPATHY; MYOCARDIAL-INFARCTION;
D O I
10.1111/jce.13307
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: No precise tools exist to predict appropriate shocks in patients with a primary prevention ICD. We sought to identify characteristics predictive of appropriate shocks in patients with a primary prevention implantable cardioverter defibrillator (ICD). Methods: Using patient-level data from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) and the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), we identified patients with any appropriate shock. Clinical and demographic variables were included in a logistic regression model to predict appropriate shocks. Results: There were 1,463 patients randomized to an ICD, and 285 (19%) had >= 1 appropriate shock over a median follow-up of 2.59 years. Compared with patients without appropriate ICD shocks, patients who received any appropriate shock tended to have more severe heart failure. In a multiple logistic regression model, predictors of appropriate shocks included NYHA class (NYHA II vs. I: OR 1.65, 95% CI 1.07-2.55; NYHA III vs. I: OR 1.74, 95% CI 1.10-2.76), lower LVEF (per 1% change) (OR 1.04, 95% CI 1.02-1.06), absence of beta-blocker therapy (OR 1.61, 95% CI 1.23-2.12), and single chamber ICD (OR 1.67, 95% CI 1.13-2.45). Conclusion: In this meta-analysis of patient level data from MADIT-II and SCD-HeFT, higher NYHA class, lower LVEF, no beta-blocker therapy, and single chamber ICD (vs. dual chamber) were significant predictors of appropriate shocks.
引用
收藏
页码:1345 / 1351
页数:7
相关论文
共 43 条
[11]   A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention [J].
Friedman, Paul A. ;
Bradley, David ;
Koestler, Celeste ;
Slusser, Joshua ;
Hodge, David ;
Bailey, Kent ;
Kusumoto, Fred ;
Munger, Thomas M. ;
Militanu, Arie ;
Glikson, Michael .
EUROPACE, 2014, 16 (10) :1460-1468
[12]   Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up [J].
Gandhi, Kaushang ;
Aronow, Wilbert S. ;
Desai, Harit ;
Amin, Harshad ;
Lai, Hoang M. ;
Frishman, William H. ;
Cohen, Martin ;
Sorbera, Carmen .
ARCHIVES OF MEDICAL SCIENCE, 2010, 6 (06) :900-903
[13]   Incidence and predictors of appropriate therapies delivered by the implantable cardioverter defibrillator in patients with ischemic cardiomyopathy: A systematic review [J].
Gracieux, Juneve ;
Sanders, Gillian D. ;
Pokorney, Sean D. ;
Lopes, Renato D. ;
Thomas, Kevin ;
Al-Khatib, Sana M. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (03) :990-994
[14]   A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial [J].
Guedon-Moreau, Laurence ;
Lacroix, Dominique ;
Sadoul, Nicolas ;
Clementy, Jacques ;
Kouakam, Claude ;
Hermida, Jean-Sylvain ;
Aliot, Etienne ;
Boursier, Michel ;
Bizeau, Olivier ;
Kacet, Salem .
EUROPEAN HEART JOURNAL, 2013, 34 (08) :605-614
[15]   Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias [J].
Higgins, SL ;
Hummel, JD ;
Niazi, IK ;
Giudici, MC ;
Worley, SJ ;
Saxon, LA ;
Boehmer, JP ;
Higginbotham, MB ;
De Marco, T ;
Foster, E ;
Yong, PG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (08) :1454-1459
[16]   Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction [J].
Hohnloser, SH ;
Kuck, KH ;
Dorian, P ;
Roberts, RS ;
Hampton, JR ;
Hatala, R ;
Fain, E ;
Gent, M ;
Connolly, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24) :2481-2488
[17]   Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy [J].
Kadish, A ;
Dyer, A ;
Daubert, JP ;
Quigg, R ;
Estes, NAM ;
Anderson, KP ;
Calkins, H ;
Hoch, D ;
Goldberger, J ;
Shalaby, A ;
Sanders, WE ;
Schaechter, A ;
Levine, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2151-2158
[18]   Assessment of Myocardial Scarring Improves Risk Stratification in Patients Evaluated for Cardiac Defibrillator Implantation [J].
Klem, Igor ;
Weinsaft, Jonathan W. ;
Bahnson, Tristram D. ;
Hegland, Don ;
Kim, Han W. ;
Hayes, Brenda ;
Parker, Michele A. ;
Judd, Robert M. ;
Kim, Raymond J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (05) :408-420
[19]   Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: Results from the NCDR® [J].
Kramer, Daniel B. ;
Kennedy, Kevin F. ;
Spertus, John A. ;
Normand, Sharon-Lise ;
Noseworthy, Peter A. ;
Buxton, Alfred E. ;
Josephson, Mark E. ;
Zimetbaum, Peter J. ;
Mitchell, Susan L. ;
Reynolds, Matthew R. .
HEART RHYTHM, 2014, 11 (02) :216-221
[20]   Characteristics and Outcomes of Patients Receiving New and Replacement Implantable Cardioverter-Defibrillators: Results From the NCDR [J].
Kramer, Daniel B. ;
Kennedy, Kevin F. ;
Noseworthy, Peter A. ;
Buxton, Alfred E. ;
Josephson, Mark E. ;
Normand, Sharon-Lise ;
Spertus, John A. ;
Zimetbaum, Peter J. ;
Reynolds, Matthew R. ;
Mitchell, Susan L. .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2013, 6 (04) :488-497